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Abstract
Fruit and vegetable consumption is associated at the population level with a protective effect against colorectal cancer.
Phenolic compounds, especially abundant in berries, are of interest due to their putative anticancer activity. After
consumption, however, phenolic compounds are subject to digestive conditions within the gastrointestinal tract that alter
their structures and potentially their function. However, the majority of phenolic compounds are not efficiently absorbed in
the small intestine and a substantial portion pass into the colon. We characterized berry extracts (raspberries, strawberries,
blackcurrants) produced by in vitro-simulated upper intestinal tract digestion and subsequent fecal fermentation. These
extracts and selected individual colonic metabolites were then evaluated for their putative anticancer activities using in vitro
models of colorectal cancer, representing the key stages of initiation, promotion and invasion. Over a physiologically-
relevant dose range (0–50 mg/ml gallic acid equivalents), the digested and fermented extracts demonstrated significant
anti-genotoxic, anti-mutagenic and anti-invasive activity on colonocytes. This work indicates that phenolic compounds from
berries undergo considerable structural modifications during their passage through the gastrointestinal tract but their
breakdown products and metabolites retain biological activity and can modulate cellular processes associated with colon
cancer.
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Introduction
The etiology of colorectal cancer, the fourth most common
cause of cancer related mortality globally, has strong associations
with diet [1,2]. Given the inverse correlation of fruit and vegetable
consumption with colorectal cancer incidence it is unsurprising
that bioactive phytochemicals within these foods are of interest
with regard to their anticancer properties [2,3]. Phenolic
compounds are abundant in soft fruit such as berries, and include
anthocyanins, flavonols, flavan-3-ols, ellagitannins, proanthocya-
nidins, hydroxycinnamates and phenolic acids [4]. These isolated
phytochemicals or whole berry extracts have been reported to
exert putative anticancer effects in colonocytes both in vitro and in
vivo [3,5,6]. For example, commercial bilberry extracts decreased
proliferation of HT29 adenocarcinoma cells in vitro [7], in tumor
cells in F344 rats treated with azoxymethane [8] and in tumor cells
from biopsies in colorectal cancer patients [9].
Berry phenolic compounds typically occur as glycosides with,
for example, anthocyanins comprising a diversity of conjugates
including glucosides, galactosides, rutinosides, xylorutinosides and
sambubiosides. Such conjugated glycosides are, for the main part,
not absorbed in the small intestine but those with a glucose moiety
may be subject to deconjugation, catalysed by membrane-bound
lactase phlorizin hydrolase in the intestinal epithelium and/or
soluble b-glucosidases, producing aglycones which are more
lipophilic and therefore absorbed by passive diffusion [10,11].
However, the majority of phenolic compounds are not efficiently
absorbed in the small intestine [4] and a substantial portion pass
into the colon [12]. Once in the large intestine, these components
are subject to degradation by the colonic microflora forming
catabolites including simple phenolic and aromatic acids [10,13].
Therefore, it is reasonable to infer that the colonic epithelium is in
direct contact with both the parent phenolic compounds and their
degradation products [14].
Generally, studies on putative anticancer activity have used in
vitro colonocyte cell models with extracts rich in phenolic
compounds or purified components from berries and have not
considered the effects of their in vivo metabolites. The initial aim of
this study was to produce and characterize extracts derived from
raspberries (Rubus idaeus L.) strawberries (Fragariax ananassa ) and
blackcurrants (Ribes nigrum L.) that were more representative of the
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components to which the colonic epithelium is exposed in vivo.
This involved a combination of in vitro digestion and subsequent
fecal fermentation of berry extracts to mimic the physiological
changes encountered during passage through the gastrointestinal
tract. The resultant extracts were then evaluated for biological
activity using in vitro models representing key stages in colorectal
cancer, namely, initiation, promotion and invasion.
Materials and Methods
Reagents
DMEM and fetal bovine serum (FBS) were obtained from
Gibco Life Technologies Ltd (Paisley, Scotland, UK). All other
chemicals were purchased from Sigma-Aldrich Company Ltd
(Dorset, England, UK) unless otherwise specified.
Berry extracts
Raspberries (Rubus idaeus L. cv. Glen Ample) and strawberries
(Fragariax ananassa cv. Elsanta) were obtained from local farmers,
around Dundee, UK, while blackcurrants (Ribes nigrum L. cultivar
8982-6) were acquired from Bradenham Hall, Norfolk, UK. No
specific permits were required for the described field studies as
these berries were part of a larger crop grown by a farmer under
contract to the James Hutton Institute and therefore not a field
study, no permissions were required. The location was not
protected in any way and no endangered or protected species
were involved. Phenolic-rich extracts of the berries were obtained
using the method of McDougall et al. [15]. In vitro digestion of the
berries was modified from the method by Gil-Izquierdo et al. [16]
as described previously [15]. Briefly, extract was obtained from the
different berry species by homogenising berries with an equal
volume of solvent (2% (v/v) glacial acetic acid in acetonitrile) in a
Waring blender (full power, 3615s), the homogenate filtered
through muslin, and the filtrate subjected to rotary evaporation to
remove the solvent. This extract then underwent an in vitro
procedure that simulates the digestive process. Two sequential
steps were performed; an initial pepsin/HCl step to simulate
gastric conditions, and bile salts/pancreatin digestion to simulate
conditions of the small intestine. This ‘colon-available’ extract
underwent solid phase extraction to remove phenolics from bile
salts present in the samples. Total anthocyanins were measured
using a pH differential technique. The extract was then diluted in
distilled water to a concentration of 500 mg gallic acid equivalents
(GAE) as measured using the Folin-Ciocalteau method and dried
in a speed-vac. Berry extract was stored at 220uC until use.
In vitro fermentation
The in vitro digested (IVD) berry extracts were subjected to in
vitro fermentation with human fecal samples to produce a sample
representative of what may be present in the colon [17] Basal
medium was prepared to sustain the fecal inoculum (in 500 mL of
water: peptone water [2 g], yeast extract [2 g], NaCl [0.1 g],
K2HPO4 [0.04 g], KH2PO4 [0.04 g], MgSO4.7H2O [0.01 g],
CaCl2.6H2O [0.01 g], NaHCO3 [2 g], Tween 89 [2 mL], hemin
[0.05 g], vitamin K (10 ml), L-cysteine HCl [0.5 g]). A further
1500 mL of water was added with stirring. Once all components
had dissolved completely the medium was dispensed in 135 mL
aliquots into glass bottles and autoclaved.
The fermentation vessels were maintained at 37uC, sterile
medium added and nitrogen gas was pumped through the vessels
to maintain anaerobic conditions. The pH was maintained at
,6.6 using the inserted pH electrodes and addition of acid and
base solutions (0.5 M HCl/0.5 M NaOH respectively).
IVD berry extract (10 mL) was added to the basal medium in
separate fermentation vessels and a control vessel constructed
without berry extract. Fecal samples were collected with the prior
approval of the ethics committee of the University of Reading.
This experiment was carried out using fecal samples from three
different volunteers. After obtaining verbal informed consent, a
standard questionnaire to collect information regarding the health
status, drugs use, clinical anamnesis, and lifestyle was administrat-
ed before the donor was asked to provide a fecal sample. The
University of Reading ethics committee exempted this study from
review because no donors were involved in any intervention and
waived the need for written consent due to the fact the samples
received were not collected by means of intervention. Fresh fecal
samples were provided by 3 apparently healthy individuals (2
males, 1 female, and age range 24–37 years, who had not taken
antibiotics within the previous 3 months). Within 2 hours of
collection, the samples were combined and 10% (w/v) fecal slurry
prepared using sterile PBS. Fecal slurry, 15 mL, was added to each
of the fermentation vessels and allowed to mix thoroughly with the
medium for 5 min and the pH adjusted accordingly. At time
T=0 h, 6 mL of fecal slurry/basal medium was removed from
each vessel, ultracentrifuged for 2610 min at 10,000 g and the
supernatant (termed fermented berry extract) filtered through
0.22 mm filters before being aliquoted into Eppendorf tubes.
Sampling was repeated at T= 24 hours and all aliquots stored at
280uC.
Liquid chromatography-mass spectroscopy
Berry extracts corresponding to 40 mg of gallic acid equivalents
(GAE) were analyzed on a LCQ-DECA system comprised of
Surveyor autosampler, pump, a photodiode array detector and a
Thermo-Finnigan ion trap mass spectrometer as outlined by
Coates et al. [18]. Phenolic components were identified on the
basis of a combination of co-chromatography with reference
compounds, retention times, and absorbance and mass spectra
(Table S1). Classes of polyphenols were quantified against relevant
standards: hydroxycinnamates as 5-O-caffeoylquinic acid equiva-
lents; flavonols as quercetin-3-O-glucoside equivalents, anthocya-
nins as cyanidin-3-O-glucoside equivalents; ellagitannins and
ellagic acids as ellagic acid equivalents and others as catechin
equivalents. Parent compounds in the berry IVD extracts were
analysed by LC-MS as described by Borges et al. [19] and phenolic
acids in fermentates by GC-MS according to procedures of Roowi
et al. [20].
Berry extracts and individual phenolics
Bermudez-Soto et al. [21] estimated that consumption of
approximately 640 mg of phenolic compounds would result in
colonic concentrations in the region of 160 mg/l. The dose range
in this study equated maximally to 50 mg/l and as such is
physiologically relevant. For experimentation, the IVD extracts
were reconstituted in growth medium to a concentration of
500 mg/mL GAE, and subsequently diluted to produce the dose
range of 50, 25, 12.5, 6.25, and 3.125 mg/mL GAE. During
experimentation cells were pre-incubated with each concentration
of berry extract for 24 hours at 37uC, 5% CO2, 95% humidity.
Fermented berry extracts were diluted 1/10 v/v with PBS prior to
testing. Individual phenolic acids were used at a similar
concentrations to those phenolic acids detected in the fermented
berry extracts by LC-MS analysis (Table 1), a common range was
selected for comparison purposes namely, 1 and 5 or 5 and 10 mg/
mL depending on the concentration of the individual phenolic
acid in the fermented extract. Twenty four hours was selected as
the exposure time for all in vitro studies as it is generally considered
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to reflect the average colonic transit time, after pre-incubation
with treatments the cells were washed and harvested with trypsin
prior to use in the various assays.
Tissue culture
Given that the colonic epithelium maybe in direct contact with
both parent phenolic compounds and their degradation products
[14] the bioactivity of berry extracts was assessed using colonocyte
cell-based assays that represent early and late stage events in
carcinogenesis, namely initiation [22,23] and invasion [24,25].
Cell lines were used as models for colorectal cancer, namely HT29
human colorectal adenocarcinoma cell line for anti-genotoxicity/
genotoxicity, mutagenicity studies and HT115 a human colon
carcinoma cell line for matrigel invasion studies. The HT29,
HT115 and MRC5 human lung fibroblast-like cells were obtained
from the European Collection of Cell Cultures, Salisbury, UK and
were cultured as described by Coates et al. [18]. HT29 (G17 neo)
cells were a gift from Professor Bill Kauffman, University of North
Carolina, USA and were maintained in DMEM supplemented
with 10% FBS.
Biological activity assays
Cytotoxicity assay. Cytotoxicity of the berry extracts on
HT29 cells treated for 24 hours was determined using the MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
colorimetric assay to assess cell viability in accordance with the
method described by Coates et al. [18]. The experiment was
repeated independently three times for each treatment and the
mean results expressed as % cell survival normalized to biological
control.
Genotoxicity assay (Comet assay). The effect of the IVD
berry extracts and fermented berry extract on colonocyte DNA
damage was determined using the Comet assay according to the
method described previously [18]. HT29 cells were pre-incubated
with the various berry extracts for 24 h. The anti-genotoxic
potential of the extract was assessed by treating pre-incubated
HT29 cells with hydrogen peroxide (75 mM H2O2). To determine
any genotoxic effects of the berry extract, pre-incubated cells were
treated with PBS instead of H2O2. Each experiment was
performed independently 3 times and presented as mean % tail
DNA normalised to control.
Matrigel invasion and migration assays. Invasion of
tumour cells through the basement membrane is an important
step in the metastasis process. Invasion itself involves multiple
stages including degradation of the extracellular matrix, adhesion
to and migration through the basement membrane. The invasion
assay was conducted as described previously [18]. Briefly, HT115
cells were incubated with medium containing the various extracts
tested for 24 h prior to experimentation and then seeded on to
MatrigelTM (ECM matrix) coated Boyden chambers (or to an
uncoated Boyden chambers when the migration assay was
conducted) and allowed to invade for 24 h in response to
chemo-attractant factor secreted by MRC 5 cells grown in the
basolateral compartment of the boyden chamber. Growth
medium was removed from the insert and cells were fixed in
70% v/v ethanol for 30 min prior to staining with haematoxylin.
The number of invasive (on basolateral membrane surface) and
non-invasive (on apical membrane surface) cells were counted in 5
random fields of view at x 20 magnification using the Kromascan
Meteor 2 software (Kinetic Imaging Ltd, Liverpool, UK), and the
percentage invasion calculated. Each experiment was repeated
independently 3 times for each treatment and expressed as %
invasion normalised to control.
Mutation frequency assay. This assay used HT29 (G17
neo) cells, which are HT29 cells (ATCC Cell Biology Collection,
USA) transfected with a construct of 17 G-bases inside the coding
sequence for the neo gene, which codes for resistance to the
antibiotic neomycin. This insertion deactivates the gene and the
cells become susceptible to neomycin, which can be reversed if a
frameshift mutation occurs. The antibiotic geneticin (G418
sulfate), an analogue of neomycin, prevents cells that lack
resistance from replicating, and thus from forming colonies. Fecal
water, the aqueous phase of the fecal stream, has been shown to
cause a 2–3 fold increase in frameshift mutations in HT29 cells
(unpublished data). In this assay, fecal water is used as a biological
control to induce a frameshift mutation, reverting cells to G418
resistance. The acridine mutagen ICR 191 induces frameshift
mutations specifically at guanine bases and was used in this assay
as a positive control [26]. The protective effect of berry extracts
against fecal water-induced mutations was assessed. Fecal water
was prepared as described by Boyd et al. [27] from a single male
donor (age 32 years) after written informed consent had been
obtained and prior to provision of the stool sample, with the
approval of the University of Ulster ethical committee.
HT29 (G17 neo) cells were seeded into 6-well tissue culture
plates at 1.56104 cells/well and incubated for 24 h at 37uC with
5% CO2 and 95% humidity. Growth medium was removed from
all wells, IVD berry extracts and fermented berry extracts added to
the test plates; growth medium was replenished in the control plate
then incubated for 24 h. Medium was removed from all wells and
the following treatments were added. Serum-free growth medium
was used as a negative control, ICR 191 at 1 mg/mL in serum-free
Table 1. Quantities of phenolic acids in fermented berry extracts.
Compound Control Raspberry Strawberry Blackcurrant
Benzoic acid 2.460.5 2.360.4 2.360.0 1.760.1
4-Hydroxybenzoic acid n.d. 0.2660.01* 0.5260.07* 0.2560*
3,4-Dihydroxybenzoic acid n.d. n.d. n.d. 0.4960.0*
Tyrosol 0.1560.0 0.3260.0* 0.3260.07* 0.1760.0
Phenylacetic acid 1664 3464* 2161.4 7.460.1
49-Hydroxyphenylacetic acid 1.560.2 3.760.5* 3.060.3* 5.360.3*
3-(Phenyl)propionic acid 1.060.3 2.160.3 3.660.2* 20.761*
3-(49-Hydroxyphenyl)propionic acid n.d. n.d. n.d. 1.760.2*
aData expressed as mean values in mg/mL 6 standard deviation. (*) indicates values significantly higher than Control figures at p,0.05; n.d, not detected.
doi:10.1371/journal.pone.0049740.t001
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growth medium and fecal water (100 mL in 900 mL serum-free
growth medium) were used as positive controls. Fecal water
(100 mL in 900 mL serum-free growth medium) was added to each
well in the test plate, and both plates were incubated for 1 h at
37uC with 5% CO2 and 95% humidity. Fecal water and controls
were removed and the cells harvested using 0.25% trypsin-EDTA.
Cells were disaggregated by needle aspiration in growth medium
and counted using a Vi-CELL counter (Beckman-Coulter Ltd,
High Wycombe, Buckinghamshire, United Kingdom). Cells were
seeded into Petri dishes (1000 cells/dish) and 8 mL growth
medium was added. Four dishes per treatment were seeded to be
grown with/without G418 in duplicate. Cells were incubated for
24 h and G418 (80 mL of 100 mg/mL) was added to half the
plates. The medium was refreshed every 3 days (replacing G418
each time). Whereas cells grown without G418 were stained after
7–10 days, cells grown with G418 were grown for up to 3 weeks.
Cells were washed with PBS and fixed in 100% methanol for
5 min, the methanol removed and left to dry. The cells were
stained with Giemsa stain (1:20 in dH2O) for 15 min. The stain
was gently rinsed off and the dishes were left to dry overnight.
Colonies were counted and the mutation frequency was calculated
for each plate using: Colony forming efficiency (CFE), mutation
frequency (MF) and relative mutation frequency (RMF):
CFE~Colonies in absence of G418=No: cells seeded
MF~ Colonies in presence of G418=CFEð Þ xNo: cells seeded
RMF~MFtest compound=MFcontrol compound
Each experiment was performed in duplicate for each treatment
(26G418+/26G4182), and repeated three times independently
and the results expressed as mean RMF.
Statistical analysis
The mean of each data set was used for statistical analysis. The
Shapiro-Wilk test was used to test for normality. Analysis of
variance was applied to test for significant differences between
means using ANOVA, Dunnett T and T3 tests. Four-way
comparisons were performed between berry types to test for
significance using Bonferroni. Significance was accepted at
p,0.05. Analysis was carried out using SPSS (version 17.0 for
Windows).
Results
In vitro digestion of berry extracts
The levels of individual phenolic compounds in the berry
extracts pre- and post-IVD samples were analysed by LC-MS and
the data obtained is summarized in Tables S1, S2, and S3 and
Figure S1. The most abundant components in raspberry extracts
were the ellagitannins, sanguiin H-10 and lambertianin C and the
anthocyanin cyanidin-3-O-sophoroside. The strawberry extracts
contained mainly anthocyanins and ellagitannins with smaller
amounts of hydroxycinnamate derivatives and flavonols, whereas
blackcurrant was dominated by four main anthocyanins which
made up ,70% of the total phenol content.
The recovery of phenolic components after IVD followed
patterns which have been outlined previously [18]. Anthocyanins
were generally less stable and the total anthocyanin content
decreased in all three berry extracts post-IVD. However, there was
no clear relationship between either the structure of the
anthocyanidin aglycone or the glycosyl group and the stability of
the anthocyanin to IVD. The stability of individual components
also differed between berry extracts (e.g. the recovery of
pelargonidin-3-O-glucoside was 52% in strawberry but 29% in
raspberry) and stability appears to be dependent on the overall
phenolic composition of each extract as suggested previously [15].
Overall, the pattern of recovery of ellagitannins suggested
breakdown. Ellagitannins in strawberry and raspberry showed
differential stability with larger components (e.g. lambertianin C
and sanguiin H10 in raspberry) being reduced in content whereas
the levels of smaller components (sanguiin H6) were either
increased or maintained. This most likely reflects the well-
documented breakdown of larger ellagitannins in slightly alkaline
conditions through loss of ellagic acid after lactonization of a
hexahydroxydiphenoyl group [28] yielding smaller ellagitannins
[29]. Flavonol components were generally more stable to IVD and
actually increased in relative yield presumably due to reductions in
other components. Hydroxycinnamate derivatives were also more
stable to IVD with e.g. a feruloyl-O-hexoside in strawberry
increasing substantially.
In vitro fermentation of berry extracts
LC-MS analysis established that phenolic compounds present at
the start of the fermentation were absent after a 24 h fecal
incubation while the levels of simpler aromatic components
increased in the fermented extracts (Table 1). The main catabolites
that increased significantly in most of the extracts were
phenylacetic acid, 3-(phenyl)propionic acid, 4-hydroxybenzoic
acid and 49-hydroxyphenylacetic acid. There were some sugges-
tions of berry-specific products as, for example, 3, 4-dihydrox-
ybenzoic acid was only identified in the fermentates from black
currant.
Cytotoxicity
No cytotoxic activity was observed for any of the IVD berry
extracts (0–50 mg/mL GAE) compared to media control (at
1.660.1 AU) (Figure 1A). Further no anti-proliferative effects were
observed as determined by growth curve and cell cycle analysis in
accordance with methods described by McCann et al. [30]. All the
fermented berry extracts were cytotoxic when used neat (recon-
stituted in 1.5 mL of growth medium) but notably were 25–50%
less cytotoxic than the control fermentate (at 1.160.1 AU). A 1:10
dilution was selected for all experiments as it represented the
lowest dilution tested at which berry fermentates and control
fermentate had no significant difference in cytotoxicity (Figure 1B).
The individual phenolics identified in IVD fermentate exerted no
cytotoxicity when tested at physiologically relevant concentrations
compared to the media control (Figure 2C).
Genotoxicity (Comet assay)
When measured by the Comet assay all IVD berry extracts
above 6.25 mg/mL GAE exerted significant dose dependent anti-
genotoxic effects on H2O2–challenged HT29 cells with no
evidence of genotoxicity when compared to the media control.
Overall, strawberry and blackcurrant IVD extracts reduced DNA
damage more effectively than raspberry (p,0.01) (Figure 2A).
Raspberry extract at maximal concentration decreased the % tail
DNA from around 50% in H2O2–challenged HT29 cells to about
15%, whereas strawberry and blackcurrant treatment reduced
levels to approximately half that value (7% tail DNA).
All berry fermentates exhibited significant anti-genotoxic
activity (p,0.001) decreasing % tail DNA to ,30% (Figure 2B)
compared to the control fermentate with no berry extract. The
total phenol levels for the berry fermentates ranged from 12–
16 mg/mL GAE and the observed reduction in tail DNA was
comparable in magnitude to that reported for IVD berry extracts
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at 12.5 mg GAE/mL. Figure 3C indicates that the individual
phenolic compounds tested had no genotoxicity activity and
decreased H2O2 – induced DNA damage by ,30% but only
tyrosol (5 mg/mL) and 49-hydroxyphenylacetic acid (5 and 10 mg/
mL), reached significance (P.0.05).
Mutation frequency assay
IVD berry extracts and fermented berry extracts did not display
any mutagenic activity. ICR 191 and fecal water challenge both
induced frameshift mutations in HT29 (G17 neo) resulting in an
increase in relative mutation frequency (RMF) of ,80%. Given
the biological relevance of fecal water [31], it was selected in
preference to the chemical mutagen ICR 191 as the challenge
agent for use in the study.
All IVD berry extracts exhibited significant anti-mutagenic
activity (.50% decrease in RMF) at all concentrations tested
compared to fecal water (Figure 3A), but there was no significant
difference between the efficacy of the individual IVD berry
extracts. The berry fermentates also induced significant reductions
in RMF post-fecal water challenge, compared to untreated
fermentate (Figure 3B). A maximum reduction in RMF of 46%
was observed with the fermented raspberry extract (RMF
=0.5460.10) and, as observed for the IVD extracts, there was no
significant difference in the efficacy of different fermentates.
Matrigel invasion assay and migration assay
Twenty four hour pre-incubation with IVD berry extracts
inhibited invasion of HT115 cells in the matrigel invasion assay
(Figure 4A). A significant dose-dependent anti-invasive effect was
observed for blackcurrant, strawberry and raspberry (3.125–
50 mg/mL GAE, P,0.05) when compared to the media control.
All invasion data for IVD berry extracts was normalized to the
invasion rate of the relevant media control (raspberry 25.7%,
strawberry 22.1%, blackcurrant 19.3%) and were comparable to
previously reported values [18]. Similarly all berry fermentates
(Figure 4B) exhibited significant (P,0.01) anti-invasive effects
reducing invasion to 40% of their respective untreated control
(27%). Again there were no significant differences in the
magnitude of effect observed between the berry fermentates.
Furthermore, it is interesting to note that the reduction in the
invasion of HT115 cells for both the IVD berry extracts and berry
fermentates occurred with no change to the basal level of
migration for the HT115 cells (data not shown) indicating that
the anti-invasive effect was unlikely to be related to cell motility,
but rather adhesion or membrane degradation.
Discussion
Phenolic compounds in the diet undergo extensive modification
by mammalian enzymes and the gut microbiota during their
transit through the human body [32]. The implication of such
metabolism on the bioactivity of berry polyphenols has not been
systematically investigated. Consequently we subjected berry
extracts to in vitro digestive and fermentative processes and used
a physiologically-relevant dose range with a 24 hour exposure to
test bioactivity using in vitro models representing key stages in colon
carcinogenesis. Where significant effects were observed for the
IVD extracts, the correspondent berry fermentates also exhibited
chemoprotective activity, as did some of the individual phenolic
compounds. Furthermore, digested and fermented extracts of
equivalent phenolic content exerted an effect of similar magnitude
in the bioassays, suggesting that products generated from in vitro
digestion and fermentation of whole berries showed similar
chemoprotective properties.
The three berry extracts used in this study contained distinct
and characteristic phenolic profiles. After IVD, certain compo-
nents were depleted. In general, anthocyanins were depleted
during the IVD process (Table S1, Figure S1) and this is in
agreement with previous studies on pomegranate, raspberry,
chokeberry and blackberry juices [15,21,33,34]. The effect of in
vitro digestion on flavonols is less well studied: generally they were
more stable during the digestive process with the recoveries of
flavonols in strawberry and blackberry extracts either increasing or
remaining constant (Table S2). Recoveries of the ellagitannins,
sanguiin H-6, sanguiin H-10, and lambertinian C were similar to
those previously reported [18]. Nevertheless, the recoveries of
phenolic compounds after IVD were dependent on the type and
composition of the individual berry extract and no general model
for phenolic stability after IVD can be proposed. This makes it all
the more relevant that digestion studies are carried out.
It is clear that both the digestive and fermentation processes
altered the polyphenol composition relative to the original extract
and thus reinforces the importance of testing physiologically-
relevant polyphenol breakdown products rather than isolated
parent compounds. The phenolic metabolites derived from colonic
fermentation of berry components may accumulate to sufficient
levels to play important roles in the colon but can be reabsorbed
into general circulation and affect other processes [35]. For
example, the urolithins being microbiota-derived catabolites of
ellagitannins and ellagic acid are more effective than the parent
compounds with respect to inhibition of the Wnt signaling
pathway [36] and Nf-kB mediated anti-inflammatory activity
[37]. It is, therefore, of interest to note that both the digested and
fermented berry extracts were effective in protecting against DNA
damage and frame-shift mutations caused by exogenous challenge
agents indicating that activity was retained after bacterial
fermentation. Furthermore, individual pure phenolic compounds
representing bacterial fermentation catabolites, namely tyrosol and
49-hydroxyphenylacetic acid, exhibited significant anti-genotoxic
activity. Similar to the trends observed for reduction of DNA
damage, all the digested and fermented berry extracts exerted a
significant (P.0.05) anti-mutagenic activity against a relevant
biological challenge (fecal water) [31], again demonstrating the
preservation of bioactivity following digestion and fermentation.
While anti-mutagenic activity has been reported for some
phenolics [38] and fruit/vegetable extracts [39,40] none consid-
ered the effects of digestion or fermentation on bioactivity.
Beyond activity related to the inhibition of the initiation of
carcinogenesis, namely DNA damage and mutation, the berry
phytochemicals also exhibited activity related to metastasis. In the
present study, IVD berry extracts reduced invasiveness in a dose
dependent manner similar to our previously reported data for an
IVD raspberry extract [18]. Again, the berry extracts retained
their activity following fermentation and significantly inhibited
Figure 1. The cytotoxic effects of various types of berry extracts on HT29 cells. (A) Effects of IVD berry extract, (B) fermented berry extract
at different dilutions in growth medium, (C) individual polyphenols- tyrosol (T), 3-(39-hydroxyphenyl)propionic acid (HPA), 4-hydroxybenzoic acid
(HBA), 49-hydroxyphenylacetic acid (HAA) at 1, 5 or 10 mg/mL concentrations. Data presented is mean of 3 independent experiments + SD. One-way
ANOVA and Dunnett T test, * p,0.05, significance is compared to media control (0 ug/mL) for A & C and against control fermentate in B. Phenol
levels for 1:10 dilution of fermented extract were raspberry 15.5, strawberry 13.9 and blackcurrant 12.4 mg/mL GAE.
doi:10.1371/journal.pone.0049740.g001
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Figure 2. The anti-genotoxic effects of various types of berry extracts on HT29 cells. (A) Effects of IVD berry extract, (B) berry fermentates
at a 1:10 dilution after 24 hr pre-incubation on DNA damage in HT29 cells challenged with 75 mM H2O2 (phenol levels for berry fermentates were
raspberry 15.5, strawberry 13.9, blackcurrant 12.4 mg/mL GAE), (C) individual polyphenols – tyrosol (T), 3-(39-hydroxyphenyl)propionic acid (HPA), 4-
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invasion of HT115 cells. Migration of HT115 cells was unaffected
by the addition of any of the berry extracts which suggests that the
berry extracts may act upon surface adhesion or enzymatic
degradation rather than on cell on motility. While a few studies
have shown that fruit extracts including mulberry have decreased
invasion in a range of cell lines including HT29 [41], HCT116
[42], A549 [43] and MDA-MB-231 [44] they did not consider the
role of digestion and fermentation on the bioactivity of the
extracts. Similar consideration should also be given to activity
related to cell proliferation as various berry extracts exhibit anti-
proliferative activity in a range of colonocyte cell lines [45]. While
it is currently beyond the scope of this paper, it would no doubt be
of interest to investigate the impact of digestion and fermentation
on such effects.
In conclusion, it would appear that berry extracts retain their
biological activity after digestion and fermentation despite
considerable structural modification and this strongly suggests
that breakdown products and individual colonic metabolites,
including, tyrosol and 49–hydroxyphenylacetic acid, can modulate
cellular processes associated with colon cancer. One can envisage
that depending on their position in the colon, epithelial cells are
likely to be exposed to varying concentrations of a mixture of
hydroxybenzoic acid (HBA), 49-hydroxyphenylacetic acid (HAA) at 1, 5 or 10 mg/mL concentrations. Data is presented as mean of 3 independent
experiments + SD. One-way ANOVA and Dunnett T test, * p,0.05, significance is compared to media control (0 mg/mL) for A & C and against control
fermentate in B. Bonferroni 4-way comparison, bars with different letters are significantly different from each other p,0.05.
doi:10.1371/journal.pone.0049740.g002
Figure 3. The anti-mutagenic effects of various types of berry extracts against fecal water-induced frameshift mutations in HT29
(G17 neo) cells. (A) Effects of IVD berry extracts, (B) berry fermentates. Data presented as mean relative mutation frequency of 3 independent
experiments + SD. One-way ANOVA and Dunnett T test, * p,0.05, significance is compared to fecal water control for A and against control
fermentate FW in B. Phenol levels for berry fermentates were raspberry 15.5, strawberry 13.9 and blackcurrant 12.4 mg/mL GAE.
doi:10.1371/journal.pone.0049740.g003
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phenolic components that have survived digestion in the upper
gastrointestinal tract and their fermentation products and this
study suggests that both sets of phenolic components can
beneficially influence events relevant to the development of colon
cancer.
Supporting Information
Figure S1 LC-MS traces for raspberry and blackcurrant
extracts (A) and IVD extracts (B). For each panel the top
trace represents the scan at 520 nm. The masses for each peak are
given along with the full scale deflection value. Peak labels
correspond with the putative identities in Table S1.
(DOCX)
Table S1 Total phenol and anthocyanin content of berry
extracts pre-simulated digestion, IVD and post SPE,
n=8.
(DOCX)
Table S2 Putative identities and quantities of (poly)-
phenolic compounds detected in berry extracts before
and after IVDa.
(DOCX)
Table S3 Putative identities of peaks detected in pre-
digested berry extracts.
(DOCX)
Figure 4. The anti-invasive effects of various types of berry extracts on HT115 cells. (A) Effects of IVD berry extracts, (B) berry fermentates.
Mean of 3 independent experiments + SD, One-way ANOVA and Dunnett T test, * p,0.05, significance is compared to media control (0 mg/mL) for A
and against control fermentate in B. Values are expressed as % cell invasion normalised to control. Berry extracts had no effect on migration of HT115
cells (data not shown). Phenol levels for berry fermentates were raspberry 15.5, strawberry 13.9, blackcurrant 12.4 mg/mL GAE.
doi:10.1371/journal.pone.0049740.g004
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